Candiderma Plus Cream

Clotrimazole + Beclomethasone + Neomycin Topical

0.025 % + 1 % + 0.5 %

Glenmark Pharmaceuticals Ltd.

Pack size	20gm
Dispensing mode
Source
Agent
Retail Price	104.60 NPR

Indications

Candiderma Plus Cream is used for: Dermatoses where secondary bacterial and candidal infection present.

Adult Dose

Topical/Cutaneous Corticosteroid-responsive dermatoses Adult: Apply cream/ointment onto affected area bid or tid.

Child Dose

Safety and efficacy not established

Renal Dose

Administration

Contra Indications

Hypersensitivity.

Precautions

For external use only. Children, elderly; pregnancy and lactation.

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Clotrimazole + Beclomethasone + Neomycin Topical : Loss of skin collagen and SC atrophy; local hypopigmentation of deeply pigmented skin; local irritation, burning, contact dermatitis

Mechanism of Action

Beclometasone controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes, fibroblasts, reverses capillary permeability and lysosomal stabilisation at the cellular level to prevent or control inflammation. Clotrimazole is a broad-spectrum antifungal which binds to phospholipids in the cell membrane altering cell wall permeability causing a loss in essential intracellular elements. Neomycin interferes w/ bacterial protein synthesis by binding to 30S ribosomal subunits.

Note

Candiderma Plus 0.025 % + 1 % + 0.5 % Cream manufactured by Glenmark Pharmaceuticals Ltd.. Its generic name is Clotrimazole + Beclomethasone + Neomycin Topical. Candiderma Plus is availble in Nepal. Farmaco Nepal drug index information on Candiderma Plus Cream is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Clotrimazole + Beclomethasone + Neomycin Topical :

Cream

Surfaz SN

Franco-Indian Pharmaceuticals Pvt. Ltd.

Gel

Clotriben G ^{1% w/w + 0.025% w/w + 0.}

Nepal Pharmaceuticals Pvt. Ltd.

Cream

Surfaz SN ^{0.025% + 1% + 0.5%}

Franco-Indian Pharmaceuticals Pvt. Ltd.

TRIAL-BN ^{1%W/V + 0.025%W/V + 0.5%W}

Chemidrug Industries Pvt. Ltd.